Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polycap for Post-Stroke Cardiovascular Risk Reduction
NCT05963568Phase 3Recruiting
- Sponsor
- NCIRE - The Veterans Health Research Institute
- Start
- Apr 2026
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, open-label trial of Polycap in ischemic stroke (2 arms), sponsored by NCIRE - The Veterans Health Research Institute. Primary endpoint: Composite vascular risk factor control at 24 months. Started Apr 2026; status: recruiting.
02
Drugs
Polycap
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05963568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05963568.